Loading clinical trials...

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT01335698

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

The purpose of this study is to describe the safety, efficacy, and pharmacokinetics of a regimen of atazanavir powder boosted with ritonavir and an optimized dual nucleoside reverse transcriptase inhi...

Lead sponsor: Bristol-Myers Squibb•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

NCT07466836 · Human Immunodeficiency Virus (HIV)

RECRUITINGNA

Stress and Pain in People Living With HIV

NCT06784908 · HIV, Depression, and more

RECRUITINGPhase 2

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

NCT06749054 · HIV-1-infection

RECRUITING

Thinking and Memory Problems in People With HIV

NCT01875588 · HIV Positive

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 9, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment160

Start dateMay 2011

Last updatedNov 9, 2018

Condition

HIV

Locations shown

Children'S National Medical Center

Washington D.C., District of Columbia

SUNY Upstate Medical University

Syracuse, New York

Local Institution

Buenos Aires, Bs As, Buenos Aires

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 9, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions